224 related articles for article (PubMed ID: 30065701)
21. Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.
Chasseloup F; Pankratz N; Lane J; Faucz FR; Keil MF; Chittiboina P; Kay DM; Hussein Tayeb T; Stratakis CA; Mills JL; Hernández-Ramírez LC
J Clin Endocrinol Metab; 2020 Jun; 105(6):1983-2005. PubMed ID: 32232325
[TBL] [Abstract][Full Text] [Related]
22. Multiple endocrine neoplasia type 4.
Lee M; Pellegata NS
Front Horm Res; 2013; 41():63-78. PubMed ID: 23652671
[TBL] [Abstract][Full Text] [Related]
23. Multiple endocrine neoplasia syndromes associated with mutation of p27.
Lee M; Pellegata NS
J Endocrinol Invest; 2013 Oct; 36(9):781-7. PubMed ID: 23800691
[TBL] [Abstract][Full Text] [Related]
24. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).
Pardi E; Mariotti S; Pellegata NS; Benfini K; Borsari S; Saponaro F; Torregrossa L; Cappai A; Satta C; Mastinu M; Marcocci C; Cetani F
Endocr Connect; 2015 Mar; 4(1):1-8. PubMed ID: 25416039
[TBL] [Abstract][Full Text] [Related]
26. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
[TBL] [Abstract][Full Text] [Related]
27. A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers.
Huang H; Qiu D; Zhou Z; Wu B; Shao L; Pu Y; He T; Wu Y; Cui D; Zhong F
Discov Oncol; 2023 Jul; 14(1):126. PubMed ID: 37432583
[TBL] [Abstract][Full Text] [Related]
28. Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
Dietrich S; Hüllein J; Lee SC; Hutter B; Gonzalez D; Jayne S; Dyer MJ; Oleś M; Else M; Liu X; Słabicki M; Wu B; Troussard X; Dürig J; Andrulis M; Dearden C; von Kalle C; Granzow M; Jauch A; Fröhling S; Huber W; Meggendorfer M; Haferlach T; Ho AD; Richter D; Brors B; Glimm H; Matutes E; Abdel Wahab O; Zenz T
Blood; 2015 Aug; 126(8):1005-8. PubMed ID: 26065650
[TBL] [Abstract][Full Text] [Related]
29. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
Lindberg D; Akerström G; Westin G
Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
[TBL] [Abstract][Full Text] [Related]
31. Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E; Brunetti A; Smiroldo V; Nappo G; Pedicini V; Vitali E; Trivellin G; Mazziotti G; Lania A
Front Endocrinol (Lausanne); 2022; 13():773143. PubMed ID: 35355569
[TBL] [Abstract][Full Text] [Related]
32. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
Pellegata NS; Quintanilla-Martinez L; Siggelkow H; Samson E; Bink K; Höfler H; Fend F; Graw J; Atkinson MJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15558-63. PubMed ID: 17030811
[TBL] [Abstract][Full Text] [Related]
33. Loss of p27
Berton S; Cusan M; Segatto I; Citron F; D'Andrea S; Benevol S; Avanzo M; Dall'Acqua A; Schiappacassi M; Bristow RG; Belletti B; Baldassarre G
Sci Rep; 2017 Apr; 7(1):595. PubMed ID: 28377607
[TBL] [Abstract][Full Text] [Related]
34. MENX and MEN4.
Pellegata NS
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):13-8. PubMed ID: 22584700
[TBL] [Abstract][Full Text] [Related]
35. Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors.
Maxwell JE; Sherman SK; Li G; Choi AB; Bellizzi AM; O'Dorisio TM; Howe JR
Cancer Genet; 2015 Sep; ():. PubMed ID: 26603463
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of the cyclin-dependent kinase inhibitor, CDKN1B, results in overgrowth and neurodevelopmental delay.
Grey W; Izatt L; Sahraoui W; Ng YM; Ogilvie C; Hulse A; Tse E; Holic R; Yu V
Hum Mutat; 2013 Jun; 34(6):864-8. PubMed ID: 23505216
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-150 suppresses p27
Oboshi W; Hayashi K; Takeuchi H; Ikeda K; Yamaguchi Y; Kimura A; Nakamura T; Yukimasa N
Oncol Lett; 2020 Nov; 20(5):210. PubMed ID: 32963616
[TBL] [Abstract][Full Text] [Related]
38. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
Ding L; Shunkwiler LB; Harper NW; Zhao Y; Hinohara K; Huh SJ; Ekram MB; Guz J; Kern MJ; Awgulewitsch A; Shull JD; Smits BMG; Polyak K
PLoS Genet; 2019 Mar; 15(3):e1008002. PubMed ID: 30893315
[TBL] [Abstract][Full Text] [Related]
39. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
[TBL] [Abstract][Full Text] [Related]
40. MENX.
Pellegata NS
Ann Endocrinol (Paris); 2012 Apr; 73(2):65-70. PubMed ID: 22542001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
